皇冠体育app

The 皇冠体育app branch of British drug maker GlaxoSmithKline () will be fined 3 billion yuan ($489 million) for paying out bribes, according to a Chinese court verdict on Friday.

Following Friday's closed-door trial of the bribery case involving GSK 皇冠体育app, the Changsha Intermediate People's Court in central 皇冠体育app's Hunan Province ruled the firm was guilty of bribing personnels in the business and imposed the fine, the biggest ever given by a Chinese court.

Meanwhile, five individuals with the firm were sentenced to two to four years in jail with reprieves for their roles in the bribery, the court said.

• 皇冠体育app eyes $20 billion investment in India in five years
• 皇冠体育app's 1st C919 airliner starts structural assembly in Shanghai
• GSK 皇冠体育app faces record fine for bribery
• Alibaba's record IPO brings new investment opportunities in 皇冠体育app
• Li vows expanding rebate to firms near Yangtze
• 'Taobao village' in 皇冠体育app
• Chinese construction supply firms to operate in Venezuela
• Shanghai gold import surges